Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma

Immune checkpoint inhibitors have changed the landscape of classic cancer treatment. However, their use is associated with the emergence of new adverse events. An elderly man with rheumatoid arthritis was started on pembrolizumab for newly diagnosed advanced lung cancer. He subsequently developed he...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Principais autores: Akagi, Yu, Awano, Nobuyasu, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Yoshimura, Hanako, Jo, Tatsunori, Takada, Kohei, Kumasaka, Toshio, Izumo, Takehiro
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7205536/
https://ncbi.nlm.nih.gov/pubmed/32009093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3889-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados